KRAS-IN-41
KRAS-IN-41 is an inhibitor of KRAS with IC50 values of <0.01 μM for KRAS G12D and KRAS G12V. KRAS-IN-41 inhibits RAS mutant cell lines, GP2D (KRAS-G12D) and SW620 (KRAS-G12V). KRAS-IN-41 can be used in cancer research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3056974-50-3
- Formule: C30H37FN10OS
- Masse moléculaire:604.74
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
KRAS-IN-41 (example 173) inhibits the activity of GP2D and SW620 cell lines (IC50s both <0.01 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 3056974-50-3
-
Masse moléculaire 604.74
-
Formule C30H37FN10OS
-
SMILES
NC1=C([C@@H](C)N(C2=NC(N3CC4(CCC5=C4C(C#N)=C(N)S5)C3)=NC(OC[C@@]6(CCC7)N7C[C@H](F)C6)=N2)CC)C=CC=N1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)